Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Sodium Oligomannate in the Prevention of PSCI
Sponsor: Nanfang Hospital, Southern Medical University
Summary
Post-stroke cognitive impairment (PSCI) is a common complication of stroke, and seriously affect the quality of survival and the survival time in patients with stroke, PSCI is still lack of effective prevention and treatment measures, the study found that gut microbiota are closely associated with stroke and cognitive diseases, sodium oligomannate can improve cognitive function of mild-to-moderate alzheimer's disease (AD) , The Expert Consensus 2021 on the Management of Post-stroke cognitive impairment states that the role of sodium oligomannate in PSCI needs to be investigated in large sample clinical trials. This study intends to explore the efficacy and safety of sodium oligomannate in the prevention of PSCI in patients with acute ischemic stroke and cognitive impairment, so as to provide a potential intervention for the prevention of PSCI.
Official title: Efficacy and Safety of Sodium Oligomannate in the Prevention of Post-stroke Cognitive Impairment in Patients With Ischemic Stroke:a Randomized, Double-blind, Exploratory Controlled Study
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
116
Start Date
2023-04-01
Completion Date
2025-12-31
Last Updated
2025-06-13
Healthy Volunteers
No
Conditions
Interventions
Sodium oligomannate
Patients with acute ischemic stroke were recruited, and after signing informed consent, those who met the inclusion/exclusion criteria were randomly assigned in a 1:1 ratio to receive treatment in the trial group (receiving sodium oligomannate)
Placebo capsule
the control group (receiving placebo capsule) for 24 weeks.
Locations (2)
Nanfang Hospital, Southern Medical University
Guangzhou, Baiyun, China
Nanfang Hospital,Southern Medical University
Guangzhou, Guangdong, China